MANCHESTER, N.H.--(BUSINESS WIRE)--Jakemans, Inc. announces today the U.S. launch of GOPO® Rosehip with Galactolipids, a natural, plant-based joint care supplement that is clinically proven in some of the most difficult-to-treat chronic joint conditions1. The product will be available at major U.S. retailers including Vitamin Shoppe in the spring of 2016.
Chronic conditions affecting the joints are wide ranging and extremely common. As the U.S. population ages, the prevalence of arthritis - one of the most common and disabling joint conditions - is expected to grow to affect 25% of U.S. adults by the year 2030.2 Experts in rheumatology and joint health believe GOPO has an important role to play in joint care, with studies suggesting that GOPO may be more effective than both acetaminophen and glucosamine.3
GOPO® Rosehip with Galactolipids is made from 100% specially cultivated natural rosehip and is the only product of its kind to contain a high level of GOPO - a key component of the rosehip which may play a valuable role in the care of joints and joint tissues.
GOPO® has been evaluated in numerous rigorously-conducted, placebo-controlled, clinical trials involving hundreds of patients with difficult-to-treat chronic joint conditions including osteoarthritis and rheumatoid arthritis. Efficacy results have been consistently positive and evidence supporting the benefits of GOPO® has been presented around the world at numerous clinical meetings and many studies have been published in peer-reviewed journals.
The extensive published research demonstrates that GOPO®4:
- Reduces joint pain – with 8 out of 10 osteoarthritis (OA) sufferers reporting pain reduction after just 3 weeks of treatment5
- Improves joint mobility – by reducing joint tenderness and swelling in patients with rheumatoid arthritis6
- Reduces the need for painkillers – with almost half of OA sufferers able to reduce their consumption of paracetamol7
- Rebuilds joint tissues and cartilage8
“GOPO® has been helping joint pain sufferers in other countries for many years,” said Jonathan Groves, President at Jakemans, Inc. “While the number of people experiencing joint problems is increasing, few newer or more effective solutions have been available to them, until now. We are excited to introduce this product to the U.S. market so that people experiencing joint problems - from senior citizens to elite athletes - can care for their joints and continue to enjoy an active lifestyle.”
GOPO® Rosehip with Galactolipids is ranked as the #3 joint care supplement in the U.K. according to syndicated sales data, where it has been widely available for more than 10 years.
About Jakemans, Inc.
Jakemans, Inc., is the U.S. subsidiary of G.R. Lane Health Products Ltd. Lanes is one of the major natural medicine companies in the UK. Lanes manufactures and markets well-known products such as Olbas®, Kalms, Quiet Life, and Jakemans® Throat & Chest™ Lozenges.
Established in the 1930s by Gilbert Lane – an early supporter of the idea that we can improve our health through diet and the use of carefully selected plants and nutrients – Lanes remains a family owned business and is chaired by Gilbert’s granddaughter, Janet Lane.
______________________________________________
1 This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
2 Hootman JM, Helmick CG. Projections of U.S. prevalence of arthritis and associated activity limitations. Arthritis Rheum. 2006; 54(1): 226–229.
3 Christensen R et al. Does the hip powder of Rose canina (rose-hip) reduce pain in osteoarthritis patients? – a meta-analysis of randomised controlled trials, Osteoarthritis Cartilage (2008)
4 These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
5 Winther, K. Apel, K and Thomsborg,G. A powder made from seeds and shells of a rose-hip subspecies (Rosa canina) reduces symptoms of knee and hip osteoarthritis. A randomised, double-blind, placebo-controlled clinical trials. Scand J Rheumatol. 2005; 34:302-308.
6 Willich SN, Rossnagel K, Roll S et al. Rose hip herbal remedy in patients with rheumatoid arthritis – a randomised controlled trial. Phytomedicine 2010; 17: 87–93
7 Christensen R et al. Does the hip powder of Rose canina (rose-hip) reduce pain in osteoarthritis patients? – a meta-analysis of randomised controlled trials, Osteoarthritis Cartilage (2008)
8 Schwager J, Richard N, Wolfram S. Anti-inflammatory and chondro-protective effects of rose-hip powder and its constituent galactolipids GOPO. Poster presentation at the World Congress of Osteoarthritis (OARSI) 2008
